Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Smith-Sørensen

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Human Mutation|January 1, 1996
CDKN2A (p16INK4A) somatic and germline mutationsB Smith-Sørensen, E Hovig
Current Protocols in Human Genetics|April 23, 2008
Detection of mutations by denaturing gradient gel electrophoresisA L Børresen-Dale, E Hovig, B Smith-Sørensen
Mutation Research|May 1, 1991
Constant denaturant gel electrophoresis, a modification of denaturing gradient gel electrophoresis, in mutation detectionHovig, Eivind, B Smith-Sørensen, et al.
Mutation Research|January 1, 1991
Constant denaturant gel electrophoresis, a modification of denaturing gradient gel electrophoresis, in mutation detectionE Hovig, B Smith-Sørensen, A Brøgger, et al.
Mutation Research|September 1, 1992
Screening for mutations in human HPRT cDNA using the polymerase chain reaction (PCR) in combination with constant denaturant gel electrophoresis (CDGE)B Smith-Sørensen, E Hovig, B Andersson, et al.
Pharmacogenetics|December 1, 1992
Detection of DNA variation in cancerE Hovig, B Smith-Sørensen, A G Uitterlinden, et al.
The Journal of Biological Chemistry|March 8, 1996
Functional analysis of Burkitt's lymphoma mutant c-Myc proteinsB Smith-Sørensen, E M Hijmans, R L Beijersbergen, et al.
Progress in Clinical and Biological Research|January 1, 1990
Screening for base mutations in the PAH and HPRT loci using the polymerase chain reaction (PCR) in combination with denaturing gradient gel electrophoresis (DGGE)A L Børresen, E Hovig, B Smith-Sørensen, et al.
British Journal of Cancer|August 14, 1998
Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene statusB Smith-Sørensen, J Kaern, R Holm, et al.
Genes, Chromosomes & Cancer|September 1, 1992
No alterations in exon 21 of the RB1 gene in sarcomas and carcinomas of the breast, colon, and lungE Hovig, B Smith-Sørensen, M C Gebhardt, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Human Mutation|January 1, 1996
CDKN2A (p16INK4A) somatic and germline mutationsB Smith-Sørensen, E Hovig
Current Protocols in Human Genetics|April 23, 2008
Detection of mutations by denaturing gradient gel electrophoresisA L Børresen-Dale, E Hovig, B Smith-Sørensen
Mutation Research|May 1, 1991
Constant denaturant gel electrophoresis, a modification of denaturing gradient gel electrophoresis, in mutation detectionHovig, Eivind, B Smith-Sørensen, et al.
Mutation Research|January 1, 1991
Constant denaturant gel electrophoresis, a modification of denaturing gradient gel electrophoresis, in mutation detectionE Hovig, B Smith-Sørensen, A Brøgger, et al.
Mutation Research|September 1, 1992
Screening for mutations in human HPRT cDNA using the polymerase chain reaction (PCR) in combination with constant denaturant gel electrophoresis (CDGE)B Smith-Sørensen, E Hovig, B Andersson, et al.
Pharmacogenetics|December 1, 1992
Detection of DNA variation in cancerE Hovig, B Smith-Sørensen, A G Uitterlinden, et al.
The Journal of Biological Chemistry|March 8, 1996
Functional analysis of Burkitt's lymphoma mutant c-Myc proteinsB Smith-Sørensen, E M Hijmans, R L Beijersbergen, et al.
Progress in Clinical and Biological Research|January 1, 1990
Screening for base mutations in the PAH and HPRT loci using the polymerase chain reaction (PCR) in combination with denaturing gradient gel electrophoresis (DGGE)A L Børresen, E Hovig, B Smith-Sørensen, et al.
British Journal of Cancer|August 14, 1998
Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene statusB Smith-Sørensen, J Kaern, R Holm, et al.
Genes, Chromosomes & Cancer|September 1, 1992
No alterations in exon 21 of the RB1 gene in sarcomas and carcinomas of the breast, colon, and lungE Hovig, B Smith-Sørensen, M C Gebhardt, et al.
Pageof 2